MCD stock · ORMP stock

MCD vs ORMP

McDonald’s Corporation (MCD) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.

McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.

Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.

Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.

Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.

MCD currently screens at market cap $201.66B and trailing P/E 23.4. ORMP currently screens at market cap $87.2M.

Not investment advice. Open the MCD and ORMP stock pages for the full models.

Not investment advice.

Popular Stock Comparisons